Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
    Company

    Enalees


    5 rue Henri Desbruères – Building 7
    91030 EVRY Cedex – FRANCE
    Phone: +33 (0)1 78 05 47 25
    Email: contact@enalees.com

    Laurent THIERY: President
    Web Site >
    Enalees - Genopole Company 2024 Enalees - Genopole Company 2024

    #Health / Well-being #Diagnostics

    • Diagnostics
    • Animal health
    • Veterinary
    • Molecular biology
    • Rapid test

    Field of Activity


    Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

    BACKGROUND

    Enalees was created in December of 2015.

    The company joined Genopole and became Genopole-accredited in February 2016. After two years of research, Enalees commercialized its first tests, Epona, for veterinarians working with horses, and a year later it brought the Astéria line to market for veterinarians working with dogs. Enalees also developed a SARS-CoV-2 diagnostic test during the COVID-19 pandemic to detect the causative virus in humans, cats, and the environment.

    DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

    The purpose of Enalees’ rapid tests is to diagnose a disease via a portable reader within 40 minutes with no need to send samples to a specialized laboratory.

    Also, in 2021, Enalees will begin offering a freeze drying service to numerous businesses thanks to its new lyophilization platform located at Genopole.

    CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

    • Financial support from Bpifrance and the Île-de-France Administrative Region
    • Accredited by the Hippolia competitiveness cluster
    • Partnership with Bertin Technologies for the BEC-SARS-CoV-2 tests
    • Upcoming launch of a lyophilization platform
    • Further information

      15 staff members
      Strengths:
      Simple and rapid detection of pathogens in less than 40 minutes on a portable and affordable device. Energetic and innovative team.

    Share
    Genopole’s Companies

    #Diagnostics


    In same field

    CGenetix - Entreprise génopolitaine

    CGenetix

    CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

    Discover
    EndoGene.Bio - Genopole's Company

    EndoGene.Bio

    Research & development for an in vitro diagnostic tool for endometriosis

    Discover
    SafeInsight - Entreprise génopolitaine

    SafeInsight

    SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

    Discover
    View all >
    With the support from
    Région île de France
    Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
    Communauté d'agglomération Grand Paris Sud
    Département de l'Essonne - Terre D'avenirs
    Ville d'Evry-Courcouronnes
2023
    CEA
    Inserm